Abstract
Next-generation sequencing has revealed that less than 2% of transcribed genes are translated into proteins, with a large portion transcribed into noncoding RNAs (ncRNAs). Among these, long noncoding RNAs (lncRNAs) represent the largest group and are pervasively transcribed throughout the genome. Dysfunctions in lncRNAs have been found in various diseases, highlighting their potential as therapeutic, diagnostic, and prognostic targets. However, challenges, such as unknown molecular mechanisms and nonspecific immune responses, and issues of drug specificity and delivery present obstacles in translating lncRNAs into clinical applications. In this review, we summarize recent publications that have explored lncRNA functions in human diseases. We also discuss challenges and future directions for developing lncRNA treatments, aiming to bridge the gap between functional studies and clinical potential and inspire further exploration in the field.
Original language | English (US) |
---|---|
Pages (from-to) | 1577-1595 |
Number of pages | 19 |
Journal | Molecular Therapy |
Volume | 31 |
Issue number | 6 |
DOIs | |
State | Published - Jun 7 2023 |
Keywords
- autoimmune disease
- cardiovascular disease
- exosomal lncRNA
- genetic disorder
- infectious disease
- lipid
- lncRNA
- lncRNA-based therapy
- neurological disease
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Genetics
- Pharmacology
- Drug Discovery